NCT05224154 Re-Connect Application for Smoking Cessation
| NCT ID | NCT05224154 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Rowan University |
| Condition | Smoking Cessation |
| Study Type | INTERVENTIONAL |
| Enrollment | 82 participants |
| Start Date | 2021-12-14 |
| Primary Completion | 2026-03-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 82 participants in total. It began in 2021-12-14 with a primary completion date of 2026-03-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This series of studies will explore the acceptability, feasibility, and preliminary efficacy of making access to smartphone applications contingent on objective evidence of smoking abstinence.
Eligibility Criteria
Inclusion Criteria: * individuals who report smoking at least 10 cigarettes per day for at least 2 years, -18 years of age or older * do not have any health complications that might interfere with the study or require more intensive treatment (e.g., emphysema, chronic obstructive pulmonary disorder, asthma, lactose intolerance) * report a strong desire to quit smoking (8 or higher on a 10-point Likert scale) * has prior experience using a smartphone, speak English, and are literate, will be eligible for the study. Exclusion Criteria: * Individuals with mental health complications that are either un-managed or that have been managed for less than 6-months
Contact & Investigator
Bethany Raiff, PhD
PRINCIPAL INVESTIGATOR
Rowan University
Frequently Asked Questions
Who can join the NCT05224154 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Smoking Cessation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05224154 currently recruiting?
Yes, NCT05224154 is actively recruiting participants. Contact the research team at raiff@rowan.edu for enrollment information.
Where is the NCT05224154 trial being conducted?
This trial is being conducted at Glassboro, United States.
Who is sponsoring the NCT05224154 clinical trial?
NCT05224154 is sponsored by Rowan University. The principal investigator is Bethany Raiff, PhD at Rowan University. The trial plans to enroll 82 participants.